Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006)

Detalles Bibliográficos
Main Authors:	Maini, R, Taylor, P, Szechinski, J, Pavelka, K, Broll, J, Balint, G, Emery, P, Raemen, F, Petersen, J, Smolen, J, Thomson, D, Kishimoto, T
Formato:	Journal article
Publicado:	2008

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
por: Maini, R, et al.
Publicado: (2006)

Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
por: Maini, R, et al.
Publicado: (2003)

Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
por: Javier Narváez, et al.
Publicado: (2015-01-01)

UK malaria treatment guidelines (vol 54, pg 111, 2007)
por: Lalloo, D, et al.
Publicado: (2009)

COMPARATIVE EVALUATION OF THE EFFICIENCY AND SAFETY OF TREATING CHILDREN WITH POLYARTICULARY JUVENILE IDIOPATHIC ARTHRITIS WITH METHOTREXATE AND WITH METHOTREXATE COMBINED WITH TOCILIZUMAB
por: V. A. Kel'tsev, et al.
Publicado: (2015-04-01)

Infliximab and methotrexate in the treatment of rheumatoid arthritis
por: Lipsky, P, et al.
Publicado: (2000)

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
por: Alison O’Mahony, et al.
Publicado: (2018-06-01)

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
por: Benucci M, et al.
Publicado: (2017-07-01)

Assessment and Comparison of the Efficacy of Methotrexate, Prednisolone, Adalimumab, and Tocilizumab on Multipotency of Mesenchymal Stem Cells
por: Shuang Liu, et al.
Publicado: (2020-07-01)

The Use of Tocilizumab in Combination with Methotrexate in Indonesian Rheumatoid Arthritis Patients (PICTURE INA Study)
por: Bambang Setyohadi, et al.
Publicado: (2018-06-01)

Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
por: Diana Prieto-Peña, et al.
Publicado: (2021-06-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
por: E. V. Udachkina, et al.
Publicado: (2015-11-01)

Dynamics of Destructive Joint Changes in Juvenile Idiopathic Arthritis in Children who Received Methotrexate or Methotrexate-Tocilizumab Combination: a Cohort Study
por: Maria A. Davydova, et al.
Publicado: (2018-01-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
por: E. V. Udachkina, et al.
Publicado: (2015-11-01)

Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study
por: Grazzini S, et al.
Publicado: (2023-12-01)

Medication-related osteonecrosis of the jaw in a patient with rheumatoid arthritis with suspected involvement of methotrexate and tocilizumab
por: Keisuke Seki, et al.
Publicado: (2024-10-01)

Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
por: Dimitrios A. Pappas, et al.
Publicado: (2020-03-01)

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
por: William R. Drobyski, et al.
Publicado: (2018-04-01)

Higgs boson searches in CP-conserving and CP-violating MSSM scenarios with the DELPHI detector (vol 54, pg 1, 2008)
por: Abdallah, J, et al.
Publicado: (2008)

Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab
por: Maria Talmon, et al.
Publicado: (2023-01-01)

Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.
por: Maria Talmon, et al.
Publicado: (2023-01-01)

Yellowstone Wolves: Science and Discovery in the Worlds First National Park. Edited by Douglas W. Smith, Daniel R. Stahler and Daniel R. MacNulty. 339 pages, London: University of Chicago Press [2020]. ISBN: 978-0226728346, €28.17 (hardcover)
por: Kilian J. Murphy
Publicado: (2022-05-01)

Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of inflixin ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis (vol 54, pg 47, 2006)
por: Taylor, P
Publicado: (2006)

Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
por: Leslie R. Harrold, et al.
Publicado: (2018-10-01)

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
por: Maini, R, et al.
Publicado: (1999)

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
por: Lipsky, P, et al.
Publicado: (2000)

Turing patterns in fish skin? (vol 380, pg 678, 1996)
por: Hofer, T, et al.
Publicado: (1996)

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.
por: Keystone, E, et al.
Publicado: (2015)

Tocilizumab (Actemra)
por: Martin Sheppard, et al.
Publicado: (2017-09-01)

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy
por: Xavier M. Teitsma, et al.
Publicado: (2017-07-01)

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
por: Maini, R, et al.
Publicado: (1998)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Masahiko Mihara, et al.
Publicado: (2011-02-01)

Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: A Markov model based on data from Serbia, country in socioeconomic transition
por: Kostić Marina, et al.
Publicado: (2014-01-01)

Tumor necrosis factor inhibitors versus janus kinase inhibitors in patients with incomplete response to methotrexate in rheumatoid arthritis
por: Kunal Chandwar, et al.
Publicado: (2023-01-01)

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
por: Xavier M Teitsma, et al.
Publicado: (2018-10-01)

Tétano. Revisão de 54 casos.
por: J Narciso, et al.
Publicado: (1992-05-01)

The efficacy of interleukin-6 inhibitor tocilizumab for takayasu’s arteritis, after insufficient response to previous treatment with glucocorticoids, methotrexate, cyclophosphamide, fludarabine. (A case report)
por: V. N. Antipova, et al.
Publicado: (2021-01-01)

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
por: Alisson Pugliesi, et al.
Publicado: (2023-07-01)

Risk Factors and Clinical Outcomes of 54 Cases of Rectal Neuroendocrine Tumors with Incomplete Resection: A Retrospective Single-Center Study
por: Li Y, et al.
Publicado: (2021-11-01)

Tocilizumab improved clinical symptoms of a patient with systemic tophaceous gout who had symmetric polyarthritis and fever: An alternative treatment by blockade of interleukin-6 signaling
por: Sho Mokuda, et al.
Publicado: (2014-01-01)

Double-blind randomized controlled clinical-trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (vol 54, pg 2817, 2006)

Títulos similares

Títulos similares